In 2020, the COVID-19 pandemic likely caused an additional 40-50,000 deaths from malaria that otherwise could have been prevented. If we do not act now to address the cause of these additional deaths and fight COVID-19 and malaria together, we will undoubtedly lose years of progress.
The Global Fund is providing guidance, tools and immediate funding of more than US$1 billion to help countries fight COVID-19, mitigate the impacts on lifesaving HIV, TB and malaria programs, and prevent fragile health systems from being overwhelmed, but they need more – $5 billion more.
This World Malaria Day urge your governments to ensure The Global Fund can protect all its hard-fought progress by increasing investments to meet their $5 billion goal.
World Malaria Day Tools:
GFAN will be launching new content each week of April leading up t...
This year, GFAN Africa and the Civil Society for Malaria Elimination (CS4ME) mobilized partners on World Mosquito Day to join in social media action to emphasize the need for countries and regional partners to work towards the elimination of malaria amid COVID -19. This is in consideration of the knock on effect that COVID-19 will cause to malaria elimination as a result of disruption of prevention, treatment and care services. Partners from the following countries joined in the twitterthon: Tanzania, Kenya, Nigeria, Zimbabwe, Burkina Faso, Sierra Leone, Cameroon and Ghana.
In 1897 Ronald Ross working in India discovered that culicine mosquitoes transmitted the avian malaria parasite Plasmodium relictum and suggested that human malaria parasites might also be transmitted by mosquitoes.This entry was posted in Blog and tagged GFAN Africa, malaria on by admin.
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
“COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years.”
“2019 marked 10 years since the historic declaration in 2009 by Eight (8) Ministers of Health to establish the Malaria Elimination 8 regional initiative under the auspice of the Southern Africa
Development Community (SADC). The mandate was clear; to draw down cases and deaths caused by malaria to zero in each member state, while addressing cross border transmission across
shared borders. This strategy was most important, requiring synchronization of interventions between common borders, and consistent dialogue between neighbouring countries, to ensure policies are in place to achieve elimination.”
Please find below a number of resources you can use for World Malaria Day. Included in the resources are a statement from GFAN Speaker Maurine Murenga, links to RBM Partnership to End Malaria resources, links to resources about COVID-19 and Malaria, and social media tools including sharable images that you adapt.
Statement from GFAN Speaker Maurine Murenga on World Malaria Day
In my community, malaria remains a persistent threat to the health and well-being of many. Malaria has tested the limits of our health infrastructure time and again and has presented a health challenge to so many, including my own family. Late last year, my youngest child was very ill and hospitalized for malaria. In the very best possible way he became one of the statistics: cured of malaria, again, thanks to investments in our health system and availability of medication and medical inter...
The 2019 G-FINDER Report: “[This] project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D) of new products to prevent, diagnose, control or cure neglected diseases in developing countries. It provides an up-to-date analysis of how R&D investments are being allocated across diseases and product types, funding trends over time, and where the potential gaps lie. This is the twelfth annual G-FINDER report, providing new data on investments made in financial
year 2018. In all, 262 organisations completed the survey for FY2018, which covered 36 neglected diseases and all relevant product types – drugs, vaccines, biologics, diagnostics, microbicides and vector control products (chemical and biological control agents, and reservoir targeted vaccines) – as well as basic research.”